MedCloud Minute
The MedCloud Minute blog is researched, fact-checked, edited and updated by the editors of MedCloudInsider.com, with writing assistance from AI. To submit your company's press release for consideration, contact [email protected].
Medtronic announced FDA approval of the Altaviva device, designed to treat urge urinary incontinence (UUI). The device is a minimally invasive, implantable tibial neuromodulation (ITNM) therapy inserted near the ankle. Altaviva is intended for patients who do not feel comfortable with invasive therapies, given the potential side effects.
The device is designed to have a 15-year battery lifespan, requiring no daily adjustments. It is MRI compatible and requires only 30 minutes of recharging. Medtronic, which has been investing heavily in connected care, is positioning Altaviva as part of its broader strategy to expand patient access and simplify treatment.
Posted by MedCloudInsider Editors on 09/26/20250 comments
The US Marine Corps has renewed its contract with defense tech company Tagup to continue using its AI-powered logistics platform, Manifest, for battlefield medical support. Manifest replaces legacy systems that often led to expired supplies, overstocked warehouses, or delayed missions. The AI tool is designed to optimize inventory management and accelerate the delivery of critical medical equipment to deployed forces.
The renewal comes as the US Marine Corps aims to adopt a modernized approach to logistics, utilizing AI to ensure speed and precision. By keeping Tagup in its toolkit, the Marine Corps signals confidence in smaller defense tech firms to deliver agile solutions alongside larger contractors. It also ensures that Marines can receive the necessary medical supplies, regardless of the condition.
Posted by MedCloudInsider Editors on 09/26/20250 comments
The Consumer Technology Association (CTA) has announced a new Health AI standard, CTA2135: Performance Verification and Validation for Predictive Health AI Solutions. This standard is designed to ensure predictive AI tools in healthcare are accurate, reliable, and ready for deployment. The announcement was made at the CTA’s Health AI+ event at Hopkins Bloomberg Center.
CTA President Kinsey Fabrizio emphasized how the new standard is aimed at helping developers to fulfill AI’s promise of solving significant challenges that address patient and provider needs.
More
Posted by MedCloudInsider Editors on 09/21/20250 comments
Olympus has launched the VISERAS OTV-S500, its newest imaging platform, designed for ear, nose, and throat (ENT) and urological procedures. The system is designed for both office and outpatient settings, offering flexible and rigid endoscope compatibility, along with a built-in lighting system that supports switching between white light, stroboscopy mode, and Narrow Band Imaging (NBI).
A key feature of the VISERA S system is its tight integration with Olympus’s content management tools, including the nCare medical recorder and VaultStream system, enabling clinicians to capture procedural recordings and share data across sites within a facility. Olympus also emphasized that NBI technology has been shown to reduce recurrence in non-muscle invasive bladder cancer (NMIBC) by about 37% over a follow-up period of 1,235 months compared with white light cystoscopy alone. The VISERA S Video is not suitable for cardiac applications, but its main features include improved color, depth, and resolution for a clear view of vascular structures.
More
Posted by MedCloudInsider Editors on 09/21/20250 comments
Eleos Health has launched Groups, a feature in its documentation platform aimed at simplifying individual speaker notes from group substance use disorder (SUD) therapy sessions. The new tool automatically produces individual speaker summaries from group sessions, whether in-person or via telehealth, while ensuring privacy standards are met to help organizations maintain compliance and reduce administrative overhead.
The Groups capability works with any EHR system and integrates with Eleos’s existing documentation tools. Audio is processed in real time in a HIPAA-compliant environment; Eleos does not save raw session audio, protecting patient privacy. According to Eleos, the solution helps clinicians generate more than 80% of progress note content, with over 90% of notes submitted within 24 hours, and reduces documentation time by over 70%.
More
Posted by MedCloudInsider Editors on 09/21/20250 comments
Intrinsic Therapeutics, a medical technology company, has successfully implanted its Barricaid Annular Closure Device in several patients while they remained awake, marking the first time this procedure has been done without general anesthesia. Dr. Ernest E. Braxton Jr., a neurosurgeon specializing in awake and minimally invasive spine surgery, performed the operations in Vail, Colorado.
The new approach uses local and regional anesthesia, enabling patients to provide real-time feedback during the procedure to confirm that nerve pressure has been relieved. Dr. Braxton has been performing awake surgery for more than a decade. Some benefits include a faster recovery period, reduced pain, and fewer risks commonly associated with general anesthesia, such as nausea or postoperative confusion.
More
Posted by MedCloudInsider Editors on 09/21/20250 comments
Lightbeam Health Solutions said on Tuesday it has received Microsoft’s AI Cloud Partner Program Healthcare AI Certified software designation for its population health management platform.
The Dallas-based company, which provides AI-enabled tools and services for care coordination, is one of 10 organizations worldwide to receive the designation. Microsoft’s certification verifies that software meets standards for security, interoperability and performance, and is designed to give healthcare providers confidence in adopting cloud-based AI systems.
More
Posted by MedCloudInsider Editors on 09/17/20250 comments
U.S. health technology company Tellihealth said on Tuesday it has added new features to its Evelyn platform, which combines remote patient monitoring (RPM) with chronic care management (CCM).
The updates include a dashboard that gives call agents and nurses real-time patient information, templates to guide remote patient assessments, a mobile app for patients to track readings and receive reminders, and a game-based feature to encourage daily participation.
More
Posted by MedCloudInsider Editors on 09/17/20250 comments
The U.S. Food and Drug Administration has granted breakthrough device designation to SpinaFX Medical’s Triojection system, a minimally invasive treatment for contained lumbar disc herniations, the Canadian company said on Wednesday.
The image-guided procedure uses a proprietary oxygen-ozone delivery system inserted into the spinal disc to reduce pressure and relieve nerve compression. The treatment can be performed on an outpatient basis in hospitals, ambulatory surgical centers, or clinics with minimal infrastructure, SpinaFX said.
More
Posted by MedCloudInsider Editors on 08/20/20250 comments
A new startup, BIOPAC Medical Systems LP, has launched following a licensing agreement between Johns Hopkins Applied Physics Laboratory, Johns Hopkins School of Medicine, and medical device firms to commercialize neural blockade monitoring technology. The device provides real-time, objective evaluation of regional anesthetic effectiveness during surgical procedures.
The technology was invented by former APL engineer Wayne Sternberger and pediatric anesthesiologist Dr. Robert Greenberg to address a critical gap in clinical care. Currently, clinicians lack reliable ways to evaluate nerve block effectiveness, particularly in vulnerable patients like children or those under general anesthesia.
More
Posted by MedCloudInsider Editors on 08/20/20250 comments
NeuroOne Medical Technologies received FDA clearance for its OneRF ablation system to treat trigeminal neuralgia, a chronic facial pain condition affecting about 150,000 Americans annually. The minimally invasive device uses radiofrequency energy to create lesions that interrupt pain signals from the trigeminal nerve. The Eden Prairie, Minnesota-based company plans a limited launch in Q4 2024, marking its first expansion into chronic pain treatment beyond neurosurgery applications. CEO Dave Rosa said the company expects to pursue additional pain management opportunities, including lower back pain treatments, leveraging its technology platform.
Posted by MedCloudInsider Editors on 08/20/20250 comments